- Home
- LANV vs RGC Comparison
LANV vs RGC Comparison
Compare LANV & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LANV
- RGC
- Stock Information
- Founded
- LANV 2015
- RGC 2014
- Country
- LANV China
- RGC Hong Kong
- Employees
- LANV N/A
- RGC N/A
- Industry
- LANV Blank Checks
- RGC Medicinal Chemicals and Botanical Products
- Sector
- LANV Finance
- RGC Health Care
- Exchange
- LANV Nasdaq
- RGC Nasdaq
- Market Cap
- LANV 196.8M
- RGC 171.1M
- IPO Year
- LANV N/A
- RGC 2021
- Fundamental
- Price
- LANV $1.64
- RGC $5.65
- Analyst Decision
- LANV
- RGC
- Analyst Count
- LANV 0
- RGC 0
- Target Price
- LANV N/A
- RGC N/A
- AVG Volume (30 Days)
- LANV 92.4K
- RGC 29.9K
- Earning Date
- LANV 08-26-2024
- RGC 10-25-2024
- Dividend Yield
- LANV N/A
- RGC N/A
- EPS Growth
- LANV N/A
- RGC N/A
- EPS
- LANV N/A
- RGC N/A
- Revenue
- LANV $409,961,427.00
- RGC N/A
- Revenue This Year
- LANV N/A
- RGC N/A
- Revenue Next Year
- LANV $76.77
- RGC N/A
- P/E Ratio
- LANV N/A
- RGC N/A
- Revenue Growth
- LANV N/A
- RGC N/A
- 52 Week Low
- LANV $0.91
- RGC $3.03
- 52 Week High
- LANV $4.70
- RGC $32.44
- Technical
- Relative Strength Index (RSI)
- LANV 48.49
- RGC 37.47
- Support Level
- LANV $1.60
- RGC $5.05
- Resistance Level
- LANV $1.82
- RGC $6.57
- Average True Range (ATR)
- LANV 0.16
- RGC 0.71
- MACD
- LANV -0.01
- RGC -0.27
- Stochastic Oscillator
- LANV 17.74
- RGC 5.25
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.